Pura Vida Investments’s Universe Pharmaceuticals Inc UPC Stock Holding History

Pura Vida Investments’s Portfolio UPC Stock Details UPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-67	Closed	-$150K	–	257
2022 Q2	$150K	Sell	67 -233	-78%	-$891K	0.01%	194
2022 Q1	$1.37M	Sell	300 -10	-3%	-$50.7K	0.04%	177
2021 Q4	$1.82M	Buy	310 +236	+319%	+$1.81M	0.07%	153
2021 Q3	$662K	Buy	+74	New	+$680K	0.02%	241

Other funds holding UPC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pura Vida Investments's UPC Position: Q3 2022 in Review

Pura Vida Investments sold out of Universe Pharmaceuticals Inc (UPC) in Q3 2022, closing a stake of 67 shares — an estimated $150K sold.

Pura Vida Investments first reported a position in UPC in Q3 2021 and held it in 4 quarters. The position peaked at $1.82M in Q4 2021. 3 funds tracked by Wall St. Rank hold UPC as of Q3 2022.

Pura Vida Investments reported no remaining Universe Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
Pura Vida Investments sold 67 Universe Pharmaceuticals Inc shares in Q3 2022, an estimated $150K.
Pura Vida Investments first reported a position in Universe Pharmaceuticals Inc in Q3 2021 and held it in 4 quarters.
Pura Vida Investments's Universe Pharmaceuticals Inc position peaked at $1.82M in Q4 2021.
3 funds tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.